December 17, 2021
Two investors, including a co-founder of Coinbase, have announced a new biotech venture that aims to solve aging by studying its epigenetic aspects. New kid on the block Long gone are the times when longevity biotech companies were scarce and poorly funded. Today, barely a week goes by without a major launch announcement, and more...